-
Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES TrialGG Schwartz, PG Steg, ODYSSEY OUTCOMES Committees and Investigators et al. -
Effects of clopidogrel vs. prasugrel vs. ticagrelor on endothelial function, inflammatory parameters, and platelet function in patients with acute coronary syndrome undergoing coronary artery stenting: a randomized, blinded, parallel studyB Schnorbus, A Daiber, T Gori et al.
-
Refractory Angina: From Pathophysiology to New Therapeutic Nonpharmacological TechnologiesG Gallone, L Baldetti, G Tzanis et al.
-
Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarctionKwong RY, Sattar H, Wu H et al.
-
No causal effects of plasma homocysteine levels on the risk of coronary heart disease or acute myocardial infarction: A Mendelian randomization studyL Miao, GX Deng, RX Yin et al.
-
Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin IY Sandoval, R Nowak, CR deFilippi et al.
-
Application of High-Sensitivity Troponin in Suspected Myocardial InfarctionJT Neumann, R Twerenbold, F Ojeda et al.
-
Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE TrialHenriques JP, Hoebers LP, EXPLORE Trial Investigators.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
